Keyphrases
Direct-acting Antivirals
59%
Oncogenic Viruses
59%
Chordoma
59%
Favorable Outcome
59%
Chronic Hepatitis C
59%
Skull Base Chordoma
59%
Cryoglobulinemic Vasculitis
59%
Parvovirus B19
34%
Sustained Virological Response
19%
Vasculitis
19%
Infection Treatment
19%
Immunosuppression
19%
Hepatitis C Virus Infection
19%
Hepatitis C Virus
19%
Quantitative PCR
17%
Immunohistochemistry
17%
In Situ Hybridization
17%
HHV-7
17%
Chondrosarcoma
17%
Epstein-Barr Virus
17%
Herpes Simplex Virus Type 1 (HSV-1)
8%
Etiology
8%
Cytomegalovirus
8%
Herpes Simplex Virus 2 (HSV-2)
8%
Viral
8%
Kaposi's Sarcoma-associated Herpesvirus
8%
Human Herpesvirus 6 (HHV-6)
8%
JC Virus
8%
Rare Tumors
8%
VP2 Capsid Protein
8%
INIS
viruses
100%
oncogenic viruses
59%
skull
59%
hepatitis
59%
patients
59%
dna
49%
humans
40%
boron 19
40%
herpes simplex
19%
in-situ hybridization
19%
symptoms
19%
immunosuppression
19%
epstein-barr virus
19%
chondrosarcomas
19%
pcr
19%
simian virus
10%
sarcomas
10%
switches
10%
etiology
10%
tumors
10%
rna
10%
proteins
10%
Medicine and Dentistry
Tumor Virus
59%
Cryoglobulinemic Vasculitis
59%
Skull Base
59%
Chordoma
59%
Chronic Hepatitis C
59%
Antivirus Agent
59%
Parvovirus B19
29%
Hepatitis C Virus
19%
Hepatitis C
19%
Immunosuppressive Treatment
19%
Vasculitis
19%
Infectious Disease Treatment
19%
Human Polyomavirus
14%
Chondrosarcoma
14%
Epstein Barr Virus
14%
Immunohistochemistry
14%
In Situ Hybridization
14%
Real Time Polymerase Chain Reaction
7%
SV40
7%
Human Alphaherpesvirus 1
7%
Merkel Cell Polyomavirus
7%
Rare Tumor
7%
Papillomaviridae
7%
Reverse Transcription Polymerase Chain Reaction
7%
Human Herpesvirus 7
7%
Human Herpesvirus 6
7%
Cytomegalovirus
7%
Herpes Simplex Virus 2
7%
Protein VP2
7%
BK Virus
7%